Copyright
©2013 Baishideng Publishing Group Co.
World J Hepatol. Nov 27, 2013; 5(11): 612-620
Published online Nov 27, 2013. doi: 10.4254/wjh.v5.i11.612
Published online Nov 27, 2013. doi: 10.4254/wjh.v5.i11.612
Table 1 Analyzed patients were 18 males and 17 females, with 17 cases of diffuse large B-cell lymphoma and nine cases of follicular lymphoma
| Characteristics of anti-HBs Ab positive patients | |
| Age (yr) | 67 (42-87) |
| Males/Females | 18/17 |
| Disease | |
| DLB | 17 |
| FL | 9 |
| MCL | 1 |
| MALT | 3 |
| Burkitt lymphoma | 1 |
| EBV associated LPD | 1 |
| WM | 1 |
| CLL | 2 |
| Stage | |
| I | 3 |
| II | 3 |
| III | 7 |
| IV | 21 |
| Chemotherapy | |
| R-CHOP | 10 |
| R-THP-COP | 20 |
| R+VP16 | 1 |
| R+MVP | 1 |
| R+TEOP | 1 |
| R+bendamustine | 1 |
| R | 2 |
| R-Course | 10 (1-30) |
- Citation: Tsutsumi Y, Yamamoto Y, Shimono J, Ohhigashi H, Teshima T. Hepatitis B virus reactivation with rituximab-containing regimen. World J Hepatol 2013; 5(11): 612-620
- URL: https://www.wjgnet.com/1948-5182/full/v5/i11/612.htm
- DOI: https://dx.doi.org/10.4254/wjh.v5.i11.612
